Health & Wellness

Are GLP-1 Drugs Quietly Rewiring How We Experience Love?

March 23, 2026

GLP-1 medications have already changed the way people talk about weight loss. But now, a newer and much messier question is entering the conversation: Can these drugs also change the way people experience love, dating, and relationships?

On the Art of Being Well, Dr. Will Cole and his clinical team dig into the growing social media debate around GLP-1 agonists like Ozempic and tirzepatide. The theory, as they explain, is rooted in the way these medications affect satiety signaling and the brain’s dopamine-driven reward centers. While it can definitely reduce food noise, it’s also what has some people wondering whether that same dampening effect could spill into other parts of life, including romance.

Why people are calling GLP-1s ‘relationship killers’

The idea that GLP-1 drugs could interfere with romance may sound dramatic, but on the podcast, Dr. Cole explains why some people are even asking the question in the first place. He points to the way GLP-1 agonists work on “satiety signaling” and the brain’s “dopamine pleasure centers,” which is part of why they can affect cravings around food, alcohol, and other compulsive behaviors.

Cole says the conversation is largely being driven by anecdotal reports online, especially from people using “higher doses of GLP-1 agonists longer term” who say “they just don’t feel that sort of butterflies in the stomach,” when it comes to their partner or romance. He adds that some people claim “their compulsion to date” or even their general interest in dating has reduced.

But he’s careful not to overstate what that means. “We do not know the long-term effect of the sort of microbiome mood axis that this could have on people,” he says, while also noting that the theory is still just that—a theory. That tension is really what’s fueling the “relationship killer” label: there is enough of a biological explanation to make people curious, but not enough hard evidence yet to say these medications are directly ruining anyone’s love life.

Falling in love is about more than dopamine

Attraction can’t be reduced to a single brain chemical. While dopamine plays a role in reward and anticipation, Cole emphasizes that “falling in love…is more multifaceted than just dopamine,” pointing to other systems like oxytocin and serotonin that shape connection, bonding, and emotional stability over time.

That distinction matters, especially when the conversation centers on “butterflies.” His team notes that the loss of that feeling isn’t necessarily a red flag. In fact, that heightened, nervous excitement can resemble a stress response early on, not a marker of long-term compatibility. If GLP-1s are dampening that intensity, it doesn’t automatically mean they’re interfering with real connection.

But take notice. If something feels different, it may not be because love is disappearing; it may be because the type of response is changing. And those are not the same thing.

The real take is much less dramatic

Cole acknowledges that the theory makes sense “on a mechanism of action” level, but he’s clear that “the real life implications of it [are] not there in the studies yet.” In other words, there’s a gap between what could be happening biologically and what’s actually been proven.

He also pointed out how many variables are at play. Changes in confidence, habits, and lifestyle while on GLP-1s can shift how people show up in relationships—which can feel like an emotional change, even if it’s not purely chemical.

If anything, Cole frames it less as a warning about love lives and more as a reminder about how these drugs are used. “We can’t beat the body into submission with peptides long term,” he says, advocating for a more intentional, balanced approach. For now, the “relationship killer” narrative says more about internet speculation than established science.

To hear the full ask me anything episode with Dr. Will Cole, listen to The Art of Being Well wherever you get your podcasts.